Company
Investors The leading provider of patient engagement tools to support efficient clinical trials
Founded in 2010, AiCure is a global technology company that delivers novel, comprehensive understanding of patients using machine learning and computer vision.
AiCure's software helps clinical trial participants with trial protocols and medication adherence while giving drug sponsors and clinical trial sites deeper understanding of treatment effects.
AiCure Highlights At-A-Glance
Only AI software platform of its kind, purposely built to utilize advanced computer vision to enhance clinical trial effectiveness
Unrivaled IP comprising a massive data lake, trained algorithms, leading predictive analytics capabilities and over 84 patents
Addressing a $3.5B market with an expanding set of use cases across clinical drug development and commercial pharma
Uniquely well positioned for expansion across decentralized clinical trials, additional therapeutic areas, and extend into commercial and population health
Led by an experienced and ambitious team of experts in pharma, life sciences, machine learning and technology
Portfolio
Growing Footprint in Clinical Trials
AiCure has supported trials across 15+ therapeutic areas:
CNS/Neurology/Neurodegeneration
Allergies/Immunology
Population Health
Women’s Health
Psychiatry
Respiratory
Oncology
Infectious Disease
Endocrinology
Cardiovascular
Dermatology
Gastrointestinal
Pediatrics
Ophthalmology
Pain
